PHR1362
Calcium Acetate
Pharmaceutical Secondary Standard; Certified Reference Material
Synonym(s):
Calcium acetate
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
Linear Formula:
(CH3CO2)2Ca
CAS Number:
Molecular Weight:
158.17
EC Number:
MDL number:
UNSPSC Code:
41116107
PubChem Substance ID:
NACRES:
NA.24
Recommended Products
![Calcium acetate hydrate [about 94% Ca(CH₃COO)₂] for soil testing](/deepweb/assets/sigmaaldrich/product/images/350/751/c4f466f3-0750-4cb4-af8f-5942eba5d12f/640/c4f466f3-0750-4cb4-af8f-5942eba5d12f.jpg)
grade
certified reference material
pharmaceutical secondary standard
Quality Level
Agency
traceable to USP 1086334
API family
calcium acetate
CofA
current certificate can be downloaded
technique(s)
HPLC: suitable
gas chromatography (GC): suitable
impurities
~1% Acetic acid
application(s)
pharmaceutical (small molecule)
format
neat
storage temp.
2-30°C
SMILES string
CC(=O)O[Ca]OC(C)=O
InChI
1S/2C2H4O2.Ca/c2*1-2(3)4;/h2*1H3,(H,3,4);/q;;+2/p-2
InChI key
VSGNNIFQASZAOI-UHFFFAOYSA-L
Looking for similar products? Visit Product Comparison Guide
General description
Calcium Acetate belongs to the group of calcium salts, widely used as phosphorus binders in patients with chronic renal failure.
Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.
Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.
Application
These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements.
Footnote
To see an example of a Certificate of Analysis for this material enter LRAA1466 in the slot below. This is an example certificate only and may not be the lot that you receive.
related product
Product No.
Description
Pricing
Storage Class Code
11 - Combustible Solids
WGK
WGK 1
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Customers Also Viewed
Daniel T Grima et al.
Current medical research and opinion, 29(2), 109-115 (2012-12-12)
The avoidance of hospitalizations and the maintenance of in-center dialysis sessions in patients receiving dialysis for end-stage renal disease (ESRD) have obvious benefits to patients, dialysis providers and payers. Benefits include better continuity of care, better patient outcomes, improved quality
Leonardo V Riella et al.
American journal of kidney diseases : the official journal of the National Kidney Foundation, 57(4), 641-645 (2011-02-22)
Hypophosphatemia is a common complication after kidney transplant, affecting >90% of patients. However, no specific recommendations for phosphate repletion exist for transplant recipients. We report a case of a 70-year-old highly sensitized woman with end-stage renal disease caused by diabetic
Meagan L Harless et al.
Environmental toxicology and chemistry, 30(7), 1637-1641 (2011-04-08)
Widespread and intensive application of road deicers, primarily road salt (NaCl), in North America threatens water quality and the health of freshwater ecosystems. Intensive use of NaCl can be harmful to sensitive members of freshwater ecosystems such as amphibians. Detection
Alastair J Hutchison et al.
Nature reviews. Nephrology, 7(10), 578-589 (2011-09-07)
The ideal serum level of phosphate in patients on dialysis, and the benefits of controlling levels of phosphate in serum remain unclear despite observational studies that associate phosphate levels with mortality. In the absence of robust data from trials, current
Rodrigo B de Oliveira et al.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 28(10), 2510-2517 (2013-08-27)
Mineral bone disorder (MBD) is an early complication of chronic kidney disease (CKD), with complex interactions in the bone-kidney-energy axis. These events lead to impaired bone remodelling, which in turn is associated with cardiovascular disease. Recently, we reported on a
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service